US Corporate Board Director Changes SEC Filings — March 12, 2026

12-03-2026

Enanta Pharmaceuticals held its Annual Meeting on March 11, 2026, where stockholders re-elected directors Bruce L.A. Carter, Ph.D. and Jay R. Luly, Ph.D.; approved an amendment to the 2019 Equity Incentive Plan to increase reserved shares by 1,600,000 despite 5,390,888 votes against; approved the say-on-pay proposal; and ratified PricewaterhouseCoopers LLP as independent auditors for the fiscal year ending September 30, 2026. All proposals passed with strong support overall, though the equity plan amendment faced notable opposition representing about 22% of votes cast.

• ·Proposal 1 (Director Elections): Carter - 20,289,217 For, 4,634,123 Withheld; Luly - 24,728,854 For, 194,486 Withheld; 1,929,393 Broker Non-Votes.
• ·Proposal 2: 19,528,223 For, 5,390,888 Against, 4,229 Abstain.
• ·Proposal 3 (Say-on-Pay): 24,228,898 For, 692,079 Against, 2,363 Abstain.
• ·Proposal 4 (Auditors): 26,825,173 For, 26,904 Against, 656 Abstain, 0 Broker Non-Votes.
• ·Definitive proxy statement filed January 26, 2026.

12-03-2026

Andrew Yun resigned as Director and Chief Compliance Officer on February 27, 2026, citing concerns about the Company’s direction and unheeded advice on Board approvals and counsel. Abe Lim resigned as Director on March 3, 2026, without any stated disagreements. On March 2, 2026, the Board approved a temporary suspension of restaurant operations to address ongoing losses, closing 12 locations with potential for more closures and several in lease defaults.

• ·Company’s California restaurants at Buena Park, Eastvale, La Mirada, Irvine, and Ontario are in lease-related defaults.
• ·Resignation letter of Andrew Yun filed as Exhibit 17.1.

12-03-2026

Sherry Barrat, a director at Arthur J. Gallagher & Co., informed the company on March 6, 2026, of her decision to retire from the Board effective May 12, 2026, upon the election of directors at the 2026 Annual Meeting of Stockholders, and she will not stand for reelection. Her retirement is not related to any disagreement with the company's operations, policies, or practices. As a result, the Board size will be reduced from ten to nine members.

• ·Filing dated March 12, 2026, reporting event of March 6, 2026.

12-03-2026

Crane NXT, Co. (NYSE: CXT) announced the appointment of Jeffrey Benck, President and CEO of Benchmark Electronics, to its Board of Directors, citing his over 35 years of experience in technology leadership across software, services, and hardware. Current Director James L.L. Tullis notified the Board on March 6, 2026, that he will not stand for reelection at the 2026 Annual Meeting of Stockholders on May 21, 2026. Chairman John S. Stroup praised Benck's addition while thanking Tullis for his contributions.

• ·Jeffrey Benck holds a Master of Science in management of technology from University of Miami and a Bachelor of Science in mechanical engineering from Rochester Institute of Technology.
• ·Filing date: March 12, 2026

12-03-2026

On March 6, 2026, the Board of Directors of Avanos Medical, Inc. increased the target value of the annual long-term incentive grant for Chief Executive Officer David C. Pacitti from $5M to $5.5M under the 2021 Long Term Incentive Plan, effective beginning in 2026. This represents a 10% increase in the CEO's target incentive compensation. No other changes or declines in executive compensation were reported.

• ·Form 8-K filed on March 12, 2026
• ·Securities traded as AVNS on New York Stock Exchange

12-03-2026

iRhythm Holdings, Inc. (NASDAQ: IRTC) appointed Jason Patten to its Board of Directors, effective March 12, 2026. Patten, currently Executive Vice President and Head of Enterprise Strategy at UnitedHealth Group since January 2022, brings extensive healthcare leadership experience from prior roles at UnitedHealth Group, OptumHealth, MoneyGram International, and Carlson Marketing Group. Chairman Abhi Talwalkar emphasized Patten's expertise in enterprise strategy, innovation, and partnerships to support iRhythm's growth toward a billion-dollar platform focused on AI, predictive care, and market expansion.

• ·Patten previously served as Chief Operating Officer and Senior Vice President of OptumHealth at UnitedHealth Group
• ·Patten holds an MBA in Business Administration from University of St. Thomas and a BS in Marketing from Minnesota State University, Mankato
• ·Investor Contact: Stephanie Zhadkevich (investors@irhythmtech.com)
• ·Media Contact: Kassandra Perry (mediarelations@irhythmtech.com)

12-03-2026

Axcelis Technologies, Inc. (Nasdaq: ACLS) announced David Ryzhik, Senior Vice President of Investor Relations and Corporate Strategy, as Interim Chief Financial Officer effective March 12, 2026, following James Coogan's departure to pursue a CFO role elsewhere; Coogan will remain until April 24, 2026, for a smooth transition. The company plans to engage an executive search firm for a permanent CFO hire. CEO Russell Low praised Ryzhik's expertise and his role in the pending merger with Veeco, while thanking Coogan for building a strong finance organization.

• ·David Ryzhik joined Axcelis in July 2024 with over 20 years of finance and investor relations experience.
• ·Axcelis has provided semiconductor solutions for over 45 years, headquartered in Beverly, Mass.

12-03-2026

Colgate-Palmolive elected Christopher S. Boerner, Ph.D., Board Chair and CEO of Bristol Myers Squibb, to its Board effective March 15, 2026, adding expertise in pharmaceuticals and healthcare. However, director Steven A. Cahillane will not stand for reelection at the May 8, 2026 Annual Meeting due to his new role as CEO of The Kraft Heinz Company.

• ·Dr. Boerner previously served as EVP, Chief Operating Officer (2023) and EVP, Chief Commercialization Officer (2018-2023) at Bristol Myers Squibb.
• ·Dr. Boerner to receive compensation as non-employee director per proxy statement filed March 26, 2025.
• ·Filing signed by Jennifer M. Daniels on March 12, 2026.

12-03-2026

Motorola Solutions, Inc. (NYSE: MSI) announced on March 12, 2026, the appointment of Peter Leav to its board of directors. Leav, a senior advisor at TPG with more than 25 years of leadership experience at software companies including McAfee (former CEO), BMC Software (former CEO), and Polycom (former CEO), brings expertise in software and cybersecurity. Chairman and CEO Greg Brown stated that Leav's track record will help drive growth as the company advances.

• ·Leav currently serves as vice chairman of the board of directors of Everfox and as a board member of New Relic.
• ·Leav previously served on the boards of Box, Proofpoint, and HD Supply.

12-03-2026

Quest Diagnostics Incorporated (NYSE: DGX) elected Timothy Wentworth, former CEO of Walgreens Boots Alliance, Evernorth Health Services, and Express Scripts, to its Board of Directors effective March 12, 2026, expanding the board to 11 members. Chairman and CEO Jim Davis highlighted Wentworth's expertise in healthcare channels, operations, and HR, while lead independent director Timothy M. Ring praised his ability to drive growth in complex healthcare companies. Quest Diagnostics serves half of U.S. physicians and hospitals and one in three American adults annually with nearly 57,000 employees.

• ·Wentworth, 65, earned a bachelor’s in industrial and labor relations from Cornell University and an associate degree in business administration from Monroe Community College.
• ·Wentworth most recently CEO of Walgreens Boots Alliance until its mid-2025 sale to Sycamore Partners; previously founding CEO of Evernorth and President/CEO of Express Scripts post-2012 Medco acquisition.

12-03-2026

Acadia Healthcare Company, Inc. (ACHC) appointed Daniel Cancelmi, former Executive Vice President and CFO of Tenet Healthcare Corporation, to its Board of Directors effective March 12, 2026. Director Wade D. Miquelon will retire at the 2026 Annual Meeting following years of service. As of December 31, 2025, Acadia operates 277 behavioral healthcare facilities with over 12,500 beds, approximately 25,000 employees serving more than 84,000 patients daily across 40 states and Puerto Rico.

• ·Appointment follows search led by Nominating and Corporate Governance Committee with executive search firm and input from Khrom Capital.
• ·Goldman Sachs and J.P. Morgan serve as financial advisors; Kirkland & Ellis LLP as legal advisor.
• ·Mr. Cancelmi's 30+ years experience includes 11 years as Tenet CFO, overseeing acquisitions like USPI and hospital divestitures.
• ·Forward-looking risks include Medicaid changes from One Big Beautiful Bill Act (OBBBA) enacted July 4, 2025.

12-03-2026

Analog Devices, Inc. held its 2026 Annual Meeting of Shareholders on March 11, 2026, resulting in the election of all ten director nominees with strong shareholder support (ranging from approximately 93% to 99% votes for). Key management proposals passed overwhelmingly, including advisory approval of named executive officer compensation (90% for), ratification of Ernst & Young LLP as auditors for fiscal year ending October 31, 2026, and approval of the Amended and Restated 2020 Equity Incentive Plan (95% for). However, the non-binding shareholder proposal on special meeting rights was rejected, receiving only 38% support.

• ·Proxy statement filed with SEC on January 23, 2026; Plan adopted by Board on December 10, 2025
• ·Broker non-votes: 30,319,338 shares across relevant proposals

12-03-2026

Blue Ridge Bankshares, Inc. (NYSE American: BRBS) announced the retirement of President and CEO G. William Beale effective March 6, 2026, following his successful leadership in exiting the OCC Consent Order in November 2025 and restoring profitability to Blue Ridge Bank. The Boards appointed Harry Golliday, Executive Vice President and Chief Credit Officer since January 2024, as Interim CEO and President of both the Company and the Bank. This transition positions the Bank to pursue growth and strategic opportunities amid a strengthened financial condition.

• ·G. William Beale joined Blue Ridge Bank as CEO on May 7, 2023, and was appointed President and CEO of the Company on July 12, 2023.
• ·Harry Golliday has over four decades of experience in financial services and joined Blue Ridge Bank in 2024.
• ·G. William Beale turned 76 in December 2025.

12-03-2026

On March 6, 2026, First United Corporation's Compensation Committee revised the Long-Term Incentive Plan (LTIP) performance-vesting RSUs to use ROAE and TBVPSG metrics relative to the 25th, 50th, and 75th percentiles of a peer group of 103 banks with $1.0B-$4.2B in assets. The Committee also approved 2026 Short-Term Incentive Plan (STIP) opportunities for executives Jason B. Rush (target $142,500), Tonya K. Sturm (target $73,593), and Robert L. Fisher, II (target $78,693), based on ROAA, efficiency ratio, delinquencies, and individual performance. No financial results or performance outcomes were reported.

• ·LTIP performance period ends December 31, 2028; RSU values based on percentage of base salary as of December 31, 2025.
• ·Peer group for LTIP is closed; acquired peers removed, failed peers assigned -99% performance.
• ·STIP payouts for 2026 to be paid in 2027; specific officer metrics confidential until 2026 results determined.
• ·STIP metrics: return on average assets, efficiency ratio, average delinquencies as percentage of total loans, individual performance.

12-03-2026

BRC Group Holdings, Inc. announced transactions resulting in the retirement of approximately $37.9 million in outstanding debt through bond-for-equity exchanges of 1,343,551 senior note units for 4,201,300 shares of common stock and cash repurchases of 171,703 units of 5.0% senior notes for $4.0 million, with a final transaction closing March 13, 2026. The company will redeem $96 million of 5.50% Senior Notes due 2026 (RILYK) on March 30, 2026, further reducing net debt beyond preliminary year-end 2025 estimates. However, due to a new auditor onboarding in September 2025 and recent 10-Q filings, the company will file a Form 12b-25 by March 17, 2026, extending the 2025 Annual Report (10-K) deadline to March 31, 2026.

• ·Transactions conducted with long-time institutional investor pursuant to Section 3(a)(9) of the Securities Act of 1933
• ·Three Quarterly Reports on Form 10-Q filed between November 20, 2025, and January 14, 2026
• ·Q4 and Full Year 2025 Financial Results and earnings call to be announced next week, with release by March 31, 2026

12-03-2026

ScanSource, Inc. announced executive changes effective March 16, 2026, with Alexandre Conde transitioning from Senior Executive Vice President, Chief People Officer to Senior Executive Vice President, Strategy. The company hired Michael Webb as its new Senior Executive Vice President, Chief Human Resources Officer, effective the same date, with the hiring occurring on March 6, 2026. The filing was signed by Michael L. Baur, President & Chief Executive Officer.

• ·Filing date: March 12, 2026
• ·Date of earliest event reported: March 6, 2026

12-03-2026

On March 9, 2026, FedEx Corporation's Board of Directors approved amendments to its FY25–FY27 and FY26–FY28 long-term incentive plans (LTI Plans) to address the impact of the planned FedEx Freight spin-off on June 1, 2026, and the shift in fiscal year end from May 31 to December 31 effective the same date. The amendments measure actual performance through FY26 and assume 100% target performance for remaining periods, resulting in weighted payouts of 67% actual/33% target for FY25–FY27 and 33% actual/67% target for FY26–FY28. These changes apply to named executive officers (NEOs) and other employees remaining with the company post-spin-off, with no alterations to underlying performance metrics.

• ·Amendments approved by Compensation and Human Resources Committee recommendation
• ·Payouts for FY25–FY27 after May 31, 2027; for FY26–FY28 after May 31, 2028
• ·Details on LTI Plans in 2025 Proxy Statement filed August 18, 2025, pages 55-60

12-03-2026

Matson, Inc. announced that John P. Lauer, Executive Vice President and Chief Commercial Officer, notified the company on March 9, 2026, of his planned retirement effective July 1, 2026. This is a routine executive transition with no additional details on successor or impact provided. No financial or operational metrics were disclosed.

• ·Filing Date: March 12, 2026
• ·Date of Earliest Event Reported: March 9, 2026
• ·SEC Items Reported: 5.02 (Departure of Directors or Certain Officers), 9.01 (Financial Statements and Exhibits)

12-03-2026

USA Rare Earth, Inc. filed an 8-K on 2026-03-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also covers Regulation FD Disclosure (Item 7.01), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). No specific details on the officer position affected, nature of the change (appointment or resignation), reasons, timing, or any quantitative financial metrics are disclosed.

• ·Data completeness: LOW (<50%). Critical missing information: Officer name, title (e.g., CEO/CFO), action (appointment/resignation/retirement), effective date, stated reason for change, board composition impact, details on Reg FD disclosure, other events, and exhibits listed.

12-03-2026

CareCloud, Inc. (CCLDO) filed an 8-K on March 12, 2026, reporting results of operations and financial condition (Item 2.02), departure or appointment of officers (Item 5.02), Regulation FD disclosure (Item 7.01), and exhibits including EX-99.1 (Item 9.01). The filing references unregistered securities sale and preliminary officer change events, but no specific financial metrics, performance comparisons, or detailed changes are provided in the available content excerpt. No positive or negative quantitative shifts identifiable due to lack of data.

• ·Filing items: 2.02 (Results of Operations), 5.02 (Officer Changes), 7.01 (Reg FD Disclosure), 9.01 (Exhibits including EX-99.1)
• ·Subcategory noted: Unregistered Securities Sale

12-03-2026

Sleep Number Corporation (SNBR) appointed Kelly F. Baker, 41, as its Controller and Principal Accounting Officer effective March 11, 2026, ending her interim role that began July 21, 2025; she has served as Controller since February 2025. Baker brings prior experience as Controller at Miromatrix Medical, Inc. (a subsidiary of United Therapeutics Corporation) from December 2021 to January 2025, and roles at Donaldson Company, Inc., The Tile Shop, and Virtual Radiologic Corporation. There are no related party transactions or special arrangements associated with the appointment.

• ·Baker served as Controller at Miromatrix Medical from December 2021 to January 2025.
• ·Baker held finance positions at Donaldson Company from February 2020 to December 2021, The Tile Shop from May 2014 to December 2019, and Virtual Radiologic from September 2007 to May 2014.
• ·Baker holds a bachelor’s degree in accounting and management from the College of Saint Benedict and an MBA from the University of Minnesota, Carlson School of Management; she is a Certified Public Accountant.

12-03-2026

Build-A-Bear Workshop (NYSE: BBW) announced a planned CEO succession: longtime CEO Sharon Price John to retire effective June 11, 2026, with Chief Operations and Experience Officer Chris Hurt appointed as successor following a transition period; Hurt will also join the Board. The move concludes a multi-year succession process aided by a consulting firm, highlighting Hurt's role in the company's turnaround, global expansion, and 5th consecutive record fiscal 2025 with $529.8M revenues. Price John will remain on the Board to support the transition.

• ·Hurt joined Build-A-Bear in 2015; Price John since 2013.
• ·Company founded in 1997; nearing 30 years of operations.
• ·Investor Relations contact: garys@buildabear.com; Media: pr@buildabear.com

12-03-2026

TIC Solutions reported full year 2025 revenue of $1.53B, up 39% from prior-year combined revenue of $1.1B, and Adjusted EBITDA of $234.1M, up 25% YoY on a combined basis, with Q4 revenue surging 94% YoY to $508.3M and Adjusted EBITDA up 87% to $76.4M, primarily due to NV5 integration. However, the company recorded a full year net loss of $87.1M (28% improved YoY but still substantial) and Q4 net loss widened to $47.2M from $15.6M, amid softness in Gulf Coast markets. TIC Solutions announced CEO succession with Ben Heraud succeeding Tal Pizzey effective March 31, 2026, identified $25M in NV5 cost synergies, and guided 2026 revenue to $2.15-2.25B and Adjusted EBITDA to $330-355M.

• ·Acuren Acquisition closed July 30, 2024; NV5 Merger closed August 4, 2025
• ·Share repurchase program authorized March 10, 2026, with no expiration date
• ·$125M revolving credit facility undrawn
• ·Approximately half of $25M cost synergies expected in 2026
• ·Earnings webcast scheduled for March 12, 2026 at 8:30 a.m. ET

12-03-2026

Angi Inc. (NASDAQ: ANGI) appointed Julie Hoarau as Chief Financial Officer effective March 27, 2026, succeeding Andrew 'Rusty' Russakoff who is stepping down after four years, during which he helped improve margins and return to profitable growth. Hoarau, Angi’s Chief Accounting Officer since October 2024, has over 20 years of finance experience, including leading accounting at MongoDB from 2019-2024 and key role in Angi's 2025 spin-off from IAC. CEO Jeff Kip expressed confidence in Hoarau's leadership for driving growth, while thanking Russakoff.

• ·Julie Hoarau served as Vice President of Accounting Operations at MongoDB from May 2019 to October 2024.
• ·Angi founded in 1995.
• ·Investor Relations contact: Eric Rattner (720) 282-1958.
• ·Corporate Communications contact: Jennifer Myers (303) 963-8352.

12-03-2026

Halozyme Therapeutics, Inc. (NASDAQ: HALO) appointed David Ramsay as Interim Chief Financial Officer effective March 23, 2026, leveraging his prior tenures as CFO from 2003-2009 and 2013-2015, during which the company grew from private to a billion-dollar public biopharmaceutical entity. The company is actively searching for a permanent CFO with a leading executive search firm. Ramsay brings over 30 years of experience in biotech finance, including roles at Bonti, Inc. sold to Allergan plc in October 2018.

• ·Ramsay previously served as SVP and CFO of Bonti, Inc. until its sale to Allergan plc in October 2018.
• ·ENHANZE® licensed to leading partners including Roche, Takeda, Pfizer, Janssen, and others.
• ·Hypercon™ licensed to Janssen, Eli Lilly, and argenx.
• ·Halozyme headquartered in San Diego, CA, with offices in Ewing, NJ; Minnetonka, MN; and Boston, MA.

12-03-2026

Quaker Chemical Corporation announced that Jeffrey Fleck no longer serves as Senior Vice President, Chief Global Operations Officer, effective March 9, 2026. His departure is an involuntary termination without cause and not related to any disagreement with the company. Subject to a release of claims, Mr. Fleck will receive severance payments and benefits under his employment agreement and company plans, as described in the March 31, 2025 Proxy Statement.

• ·Fleck Employment Agreement dated January 23, 2023, effective February 27, 2023
• ·Proxy Statement filed March 31, 2025
• ·Filing signed March 12, 2026

12-03-2026

CEA Industries Inc. (NASDAQ: BNC) appointed Brent Miller as Chief Financial Officer effective March 9, 2026, to support its BNB digital asset treasury strategy as the world's largest corporate holder of BNB. Miller brings over 20 years of experience in financial reporting, accounting, internal controls, and capital markets, most recently as Chief Accounting Officer at Figure Technology Solutions. CEO David Namdar highlighted Miller's expertise in strengthening governance and executing the BNB strategy amid growth opportunities.

• ·Press release issued March 10, 2026; SEC filing date March 12, 2026.
• ·Miller previously served as CFO of reAlpha Tech Corp., CAO of Sunlight Financial Holdings Inc., CFO and Treasurer of KKR Real Estate Finance Trust Inc., and held roles at Fortress Investment Group LLC.
• ·Miller holds B.S.B.A. in Accounting and Finance and B.S. in Computer Information Science from The Ohio State University.

12-03-2026

On March 6, 2026, the Compensation Committee of Boston Omaha Corp's Board of Directors approved an increase in base salary for Adam K. Peterson, President and CEO, to $739,000 per year, effective retroactively from January 1, 2026. This marks the first salary adjustment since January 2023. No departures, elections, or other officer changes were reported.

• ·Compensation Committee of the Board of Directors made the decision.
• ·Filing signed by Joshua P. Weisenburger, CFO, on March 12, 2026.
• ·Includes Exhibit 104: Cover Page Interactive Data File.

12-03-2026

Schrodinger, Inc. appointed Therese Abrams, age 42 and Vice President, Corporate Controller since July 2025, as its Principal Accounting Officer effective March 8, 2026. This follows Jenny Herman's transition out of her role as Chief Accounting Officer and principal accounting officer on March 6, 2026, with Ms. Herman remaining employed through April 10, 2026 to facilitate a smooth handover. No changes were made to Ms. Abrams' compensatory arrangements, and there are no family relationships or conflicting interests.

• ·Ms. Abrams joined Schrodinger in May 2013 and held progressive finance roles, including VP Finance (Jan 2023-Jul 2025) and Executive Director, Finance (Jan 2020-Jan 2023).
• ·Prior experience: Revenue Manager at Jive Software (2011-2013), Senior Financial Analyst at EVRAZ North America (2010-2011), Senior Associate at KPMG (2006-2010).
• ·Ms. Abrams holds a B.S. in Accounting from Oregon State University and is a certified public accountant.
• ·No arrangement or understanding with any other person for the designation; entered standard indemnification agreement.

12-03-2026

TriMas Corporation announced the departure of Named Executive Officer Jill S. Stress, effective March 27, 2026. In connection with her departure, Ms. Stress is expected to receive benefits under the Company's Executive Severance/Change in Control Policy dated August 11, 2021, contingent on executing a customary release of claims. The 8-K filing was made on March 12, 2026, and signed by Jodi F. Robin, General Counsel and Secretary.

• ·Date of earliest event reported: March 9, 2026
• ·Company headquarters: 38505 Woodward Avenue, Suite 200, Bloomfield Hills, Michigan 48304
• ·Common stock trading symbol: TRS on The NASDAQ Stock Market LLC

12-03-2026

Next Technology Holding Inc. held its annual stockholder meeting on March 9, 2026, electing four independent directors—Wenbo Li, Guang Cui, Gwanggeun Jo, and Hsiu Wu—with overwhelming support (over 95% FOR votes for each). Hsiu Wu was elected Board Chairman, and all four were appointed to the Audit, Compensation, and Nominating Committees. Stockholders ratified auditor CHI-LLTC (99.9% FOR) and approved business strategies (92.6% FOR), though with moderate turnout of 60.72% of 4,882,556 outstanding shares.

• ·Proposal 1 votes: Wenbo Li (2,842,698 FOR, 3,647 AGAINST, 94 ABSTAIN); Guang Cui (2,842,994 FOR, 3,224 AGAINST, 219 ABSTAIN); Gwanggeun Jo (2,842,481 FOR, 3,785 AGAINST, 172 ABSTAIN); Hsiu Wu (2,842,841 FOR, 2,849 AGAINST, 748 ABSTAIN)
• ·Proposal 2 (auditor): 2,961,421 FOR, 2,548 AGAINST, 744 ABSTAIN
• ·Proposal 3 (strategies): 2,745,703 FOR, 100,014 AGAINST, 686 ABSTAIN

12-03-2026

L3Harris Technologies appointed Sam Mehta as President overseeing both the Space & Mission Systems and Communications & Spectrum Dominance segments, effective immediately, following the departure of Jon Rambeau, former President of Communications & Spectrum Dominance. Mehta, with 25 years of aerospace and defense leadership experience, previously led the Communication Systems segment and recently assumed Space & Mission Systems; he will report to CEO Christopher Kubasik alongside Ken Bedingfield, President of Missile Solutions. The company expects to maintain separate financial reporting for its three segments.

• ·Mehta previously led L3Harris’ Communication Systems segment and assumed responsibility for Space & Mission Systems earlier this year.
• ·The leadership structure supports three reportable business segments: Space & Mission Systems, Communications & Spectrum Dominance, and Missile Solutions.

12-03-2026

Karman Space & Defense (NYSE: KRMN) announced a CEO transition effective March 23, 2026, with Tony Koblinski retiring after leading the company since its 2020 founding through its IPO and four acquisitions, while continuing as a Director. Jon Rambeau, a 30-year defense industry veteran and former president of L3Harris Technologies' $8B Communications & Spectrum Dominance segment, was unanimously selected by the board to lead the next phase of growth. No financial declines or flat metrics were reported, with emphasis on the company's position serving over 80 customers across 130 space and defense programs.

• ·Company founded in 2020 with nearly 50 years of underlying success
• ·Headquartered in Huntington Beach, Calif., with multiple U.S. facilities
• ·Jon Rambeau holds BS in mechanical engineering from Drexel University and MS in technology management from Wharton School and University of Pennsylvania

12-03-2026

Eightco Holdings Inc. (ORBS) secured $125M in institutional funding commitments, led by $75M from Bitmine (NYSE: BMNR), $25M from ARK Invest, and $25M from Payward (Kraken's parent), to expand into AI, blockchain, and digital platforms. ORBS closed strategic investments of $50M in OpenAI and $25M in Beast Industries (MrBeast), appointed Tom Lee as board director and Brett Winton as advisor; however, Dan Ives stepped down as Chairman.

• ·Supported by additional investors including World Foundation, Coinfund, Discovery Capital Management, FalconX, Pantera, and GSR.
• ·ORBS continues to hold Worldcoin and Ethereum as long-term assets.
• ·Bitmine plans to launch MAVAN staking infrastructure in Q1 2026.
• ·Beast Philanthropy has provided over 20 million free meals.

12-03-2026

On March 6, 2026, the Federal Home Loan Bank of Pittsburgh received Federal Housing Finance Agency non-objection to its 2026 Executive Officer Incentive Compensation Plan, providing NEOs with target incentive opportunities of 55%-80% of base salary based on weighted goals including profitability (30%), core credit products (20%), and technology resiliency (20%). The plan structures payouts with 50% as current award in 2027 and deferred installments through 2030, subject to performance criteria. The Chief Technology and Operations Officer retired effective January 27, 2026, with no other changes to officer positions noted.

• ·Deferred incentive award installments: up to 33 1/3% each in 2028, 2029, 2030, contingent on Bank performance and continued employment.
• ·Clawback provisions allow Board to reduce awards for operational errors, untimely filings, or insufficient remediation of supervisory findings.

12-03-2026

The Dixie Group, Inc. (DXYN) adopted an incentive compensation plan effective March 12, 2026, applicable to its Chief Executive Officer, Principal Financial Officer, and other named executive officers. The plan provides for cash awards and restricted stock awards, including Primary Long Term Incentive Plan (PLTI) and Career Share awards, similar to prior years. Forms of the awards and a summary of the plan are filed as exhibits.

12-03-2026

Sanmina Corporation held its 2026 Annual Meeting of Stockholders on March 9, 2026, where shareholders elected all eight director nominees, ratified PricewaterhouseCoopers LLP as independent auditors for the fiscal year ending October 3, 2026, approved advisory compensation for named executive officers, and authorized an additional 1,200,000 shares under the 2019 Equity Incentive Plan. However, a stockholder proposal for an independent board chairman policy was rejected by an overwhelming margin (5.8M for vs. 42.7M against), and several director elections faced notable opposition, including Mythili Sankaran (20.9M against) and David V. Hedley III (8.0M against). Broker non-votes totaled 2,621,828 shares across most proposals.

• ·Record date for stockholders: January 16, 2026
• ·2019 Plan expires on December 3, 2028
• ·Say-on-pay approval: 39,455,563 for vs. 9,020,980 against

12-03-2026

Coastal Financial Corporation (CCB) appointed Jeffrey M. Chapman, a seasoned financial technology executive with more than 25 years of experience in banking technology, digital transformation, payments, and data-driven platforms, to its Board of Directors effective March 11, 2026, expanding the Board to twelve directors. Mr. Chapman is expected to serve on the Technology Committee and the CCBX Oversight Committee, with compensation in line with the non-employee director program detailed in the 2025 Proxy Statement and December 31, 2025 Form 10-K. There are no related arrangements, understandings, or material transactions involving Mr. Chapman.

• ·Proxy Statement filed April 17, 2025
• ·Form 10-K for December 31, 2025 filed February 27, 2026
• ·No arrangements or understandings for Mr. Chapman's selection as director
• ·No material interest transactions under Item 404(a) of Regulation S-K

12-03-2026

Adobe reported record Q1 FY2026 revenue of $6.40B, up 12% YoY, with subscription revenue growing 13% to $6.20B, record operating cash flow of $2.96B, and AI-first ARR more than tripling YoY; Business Professionals & Consumers segment rose 16% to $1.78B while Creative & Marketing Professionals increased 12% to $4.39B. However, CEO Shantanu Narayen announced plans to transition after a successor is appointed, with Frank Calderoni appointed to lead the search committee. Q2 FY2026 revenue guidance is $6.43B-$6.48B, with FY2026 targets reaffirmed excluding pending Semrush acquisition.

• ·GAAP operating income $2.42B (up from $2.16B YoY); non-GAAP $3.04B.
• ·Q2 FY2026 GAAP EPS guidance $4.35-$4.40; non-GAAP $5.80-$5.85.
• ·Cash and equivalents $6.33B as of Feb 27, 2026 (up from $5.43B prior quarter).
• ·Share repurchases $2.48B in Q1 FY2026.